• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名III型成骨不全女童中COL1A1基因第43外显子c.3064G>A、Gly1022Ser错义突变的鉴定。

Identification of a missense mutation of c.3064G>A, Gly1022Ser in exon 43 of COL1A1 gene in a girl with osteogenesis imperfecta type III.

作者信息

Chen C P, Lin S P, Suo Y N, Chern S R, Su J W, Wang W

机构信息

Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.

出版信息

Genet Couns. 2012;23(3):359-65.

PMID:23072183
Abstract

Osteogenesis imperfecta (OI) types I-V have been inherited in an autosomal dominant pattern. OI type I is associated with mutations in COL1A1 mostly due to a null allele. OI types II-IV are associated with mutations in COL1A1 or COL1A2 and mostly are due to glycine substitutions. It has been suggested that the effect of glycine substitutions is position specific, and the substitution of glycine by serine has much less lethal effect than the substitutions by valine, aspartic acid, glutamic acid, arginine and cysteine. We report identification of c.3064G>A, GGT>AGT, Gly1022Ser (Gly(844) --> Ser844 in triple helix) in exon 43 of the COL1A1 gene in an 8-year-old girl with OI type III. Our report provides evidence that at triple helix glycine residue 844 (p.Gly1022), a glycine substitution by serine can result in OI type III but not a lethal outcome.

摘要

Ⅰ-Ⅴ型成骨不全症(OI)以常染色体显性模式遗传。Ⅰ型OI主要与COL1A1基因突变有关,多因无效等位基因所致。Ⅱ-Ⅳ型OI与COL1A1或COL1A2基因突变有关,多因甘氨酸替代所致。有人提出,甘氨酸替代的影响具有位置特异性,且丝氨酸替代甘氨酸的致死效应远低于缬氨酸、天冬氨酸、谷氨酸、精氨酸和半胱氨酸替代所致的效应。我们报告了在一名8岁Ⅲ型OI女童的COL1A1基因第43外显子中鉴定出c.3064G>A、GGT>AGT、Gly1022Ser(三螺旋中Gly(844) --> Ser844)。我们的报告提供了证据,表明在三螺旋甘氨酸残基844(p.Gly1022)处,丝氨酸替代甘氨酸可导致Ⅲ型OI,但不会导致致死结果。

相似文献

1
Identification of a missense mutation of c.3064G>A, Gly1022Ser in exon 43 of COL1A1 gene in a girl with osteogenesis imperfecta type III.一名III型成骨不全女童中COL1A1基因第43外显子c.3064G>A、Gly1022Ser错义突变的鉴定。
Genet Couns. 2012;23(3):359-65.
2
Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV.I-IV型成骨不全患者中的33种新的COL1A1和COL1A2突变
Hum Mutat. 2001 May;17(5):434. doi: 10.1002/humu.1124.
3
Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.成骨不全患者中COL1A1或COL1A2突变类型与听力损失之间缺乏相关性。
Hum Mutat. 2004 Aug;24(2):147-54. doi: 10.1002/humu.20071.
4
Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.I型胶原蛋白中的Y位半胱氨酸替代(α1(I) R888C/p.R1066C)与成骨不全/埃勒斯-当洛综合征表型相关。
Hum Mutat. 2007 Apr;28(4):396-405. doi: 10.1002/humu.20456.
5
Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.韩国成骨不全患者I型胶原蛋白基因的突变谱
Hum Mutat. 2006 Jun;27(6):599. doi: 10.1002/humu.9423.
6
Variable expressivity of osteogenesis imperfecta in a Brazilian family due to p.G1079S mutation in the COL1A1 gene.由于COL1A1基因中p.G1079S突变,一个巴西家庭中出现了成骨不全的可变表达。
Genet Mol Res. 2012 Sep 13;11(3):3246-55. doi: 10.4238/2012.September.12.7.
7
A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.一个中国家庭中导致Ⅰ型成骨不全症的COL1A1基因新型RNA剪接突变
Clin Chim Acta. 2008 Dec;398(1-2):148-51. doi: 10.1016/j.cca.2008.07.030. Epub 2008 Aug 5.
8
Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV.对诊断为I-IV型成骨不全症患者的COL1A1和COL1A2进行突变分析。
Hum Mutat. 2006 Jul;27(7):716. doi: 10.1002/humu.9430.
9
Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.以色列成骨不全症患者的基因与生化分析
Hum Mutat. 2004 Apr;23(4):399-400. doi: 10.1002/humu.9230.
10
Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.I型胶原蛋白基因的突变导致人类成骨不全。
Acta Biochim Pol. 2002;49(2):433-41.

引用本文的文献

1
Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches.成骨不全症发病机制与治疗方法的新进展
ACS Pharmacol Transl Sci. 2024 Jan 2;7(1):72-96. doi: 10.1021/acsptsci.3c00324. eCollection 2024 Jan 12.